The integrated 31-gene expression profile (i31-GEP) test for cutaneous melanoma outperforms CP-GEP at identifying patients who can safely forego sentinel lymph node biopsy
Main Article Content
Keywords
integrated 31-gene expression profile, i31-GEP, cutaneous melanoma, CP-GEP, prognosis, sentinel lymph node biopsy
References
1. National Comprehensive Cancer Guidelines, v2, 2022
2. Vickers et al. BMJ 2015
3. Vickers et al. Diagn Progn Res. 2019
4. Whitman et al. JCO PO 2021
5. Vetto et al. Future Oncology. 2019
6. Hsueh et al. JCO PO 2021
7. Jarell et al. JAAD. 2022
8. Arnot et al. AJS. 2021
9. Dillon et al. CMRO.2022
10. Ahmed et al. Cancer Med. 2022
11. Bellomo et al. JCO PO 2020
12. Yousaf et al. IJD 2021
13. Mulder et al. BJD 2020
2. Vickers et al. BMJ 2015
3. Vickers et al. Diagn Progn Res. 2019
4. Whitman et al. JCO PO 2021
5. Vetto et al. Future Oncology. 2019
6. Hsueh et al. JCO PO 2021
7. Jarell et al. JAAD. 2022
8. Arnot et al. AJS. 2021
9. Dillon et al. CMRO.2022
10. Ahmed et al. Cancer Med. 2022
11. Bellomo et al. JCO PO 2020
12. Yousaf et al. IJD 2021
13. Mulder et al. BJD 2020